Invitation to Episurf Medical’s Q4 2021 presentation
Episurf Medical hereby invites you to a webcasted presentation in connection with the publishing of the Q4 report, the fourth quarterly report for the fiscal year 2021. The report will be published at 08.30 (CET) on February 11th and available as of this time at www.episurf.com.
The presentation will be held in English by CEO Pål Ryfors and Head of Sales OUS Stephen Caswell, and afterwards questions are invited.
Date: February 11th 2022
Start time: 10:00 (CET)
Location: https://www.finwire.tv/webcast/episurf/q4-2021/
An on-demand version of the webcast will be available at Episurf Medical’s website after closing of the presentation.
Questions are welcome in advance by e-mail to: ir@episurf.com.
CisionBlockPro\Cision\FeedItem Object
(
[HtmlCompanyInformation:protected] =>
[HtmlContact:protected] =>
[HtmlTitle:protected] => <h1 style="line-height:120%;"><span style="font-family:arial,helvetica,sans-serif"><strong>Invitation to Episurf Medical’s Q4 2021 presentation</strong></span></h1>
[HtmlHeader:protected] =>
[HtmlIntro:protected] =>
[Body:protected] => Episurf Medical hereby invites you to a webcasted presentation in connection with the publishing of the Q4 report, the fourth quarterly report for the fiscal year 2021. The report will be published at 08.30 (CET) on February 11th and available as of this time at www.episurf.com.
The presentation will be held in English by CEO Pål Ryfors and Head of Sales OUS Stephen Caswell, and afterwards questions are invited.
Date: February 11th 2022
Start time: 10:00 (CET)
Location: https://www.finwire.tv/webcast/episurf/q4-2021/
An on-demand version of the webcast will be available at Episurf Medical’s website after closing of the presentation.
Questions are welcome in advance by e-mail to: ir@episurf.com.
[HtmlBody:protected] => <p style="margin-bottom:11px;margin-top:12px"><span><span style="font-size:11pt"><span><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">Episurf Medical hereby invites you to a webcasted presentation in connection with the publishing of the Q4 report, the fourth quarterly report for the fiscal year 2021. The report will be published at 08.30 (CET) on February 11th and available as of this time at </span></span></span><a href="https://www.episurf.com" style="color:#0563c1; text-decoration:underline"><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">www.episurf.com</span></span></span></a><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">. </span></span></span></span></span></span></span></p>
<p style="margin-bottom:11px"><span><span><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">The presentation will be held in English by CEO Pål Ryfors and Head of Sales OUS Stephen Caswell, and afterwards questions are invited. </span></span></span></span></span></p>
<p style="margin-bottom:11px"><span><span style="font-size:11pt"><span><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif">Date: February 11th 2022<br>
Start time: 10:00 (CET)<br>
Location: </span></span></span><a href="https://www.finwire.tv/webcast/episurf/q4-2021/" style="color:#0563c1; text-decoration:underline" target="_blank">https://www.finwire.tv/webcast/episurf/q4-2021/</a></span></span></span></span></p>
<p style="margin-bottom:11px"><span><span style="font-size:11pt"><span><span style="font-family:arial,helvetica,sans-serif"><span style="font-size:10pt"><span style="background-color:white"><span><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">An on-demand version of the webcast will be available at Episurf</span></span></span></span></span><span style="font-size:10pt"><span><span style="font-family:arial,helvetica,sans-serif"> Medical’s website<span style="background-color:white"><span style="color:black"> after closing of the presentation.</span></span></span></span></span></span></span></span></span></p>
<p style="margin-bottom:11px"><span><span><span style="font-size:10pt"><span style="background-color:white"><span><span style="font-family:arial,helvetica,sans-serif"><span style="color:black">Questions are welcome in advance by e-mail to: ir@episurf.com.</span></span></span></span></span></span></span></p>
[ServiceCategories:protected] => Array
(
[0] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => Twitter
[Name:protected] => Twitter
[Value:protected] => 9341
)
[1] => CisionBlockPro\Cision\ServiceCategory Object
(
[ServiceName:protected] => LinkedIn
[Name:protected] => LinkedIn
[Value:protected] => 12311
)
)
[LogoUrl:protected] => https://mb.cision.com/Public/14691/logo/96c29c854b230ac3_org.png
[CompanyInformation:protected] =>
[Contact:protected] =>
[Header:protected] =>
[Keywords:protected] => Array
(
[0] => Episurf Medical
[1] => EpiSurf
[2] => Pål Ryfors
)
[QuickFacts:protected] => Array
(
)
[Categories:protected] => Array
(
)
[Videos:protected] => Array
(
)
[Files:protected] => Array
(
[0] => CisionBlockPro\Cision\File Object
(
[IsMain:protected] => 1
[MediaType:protected] => File
[Url:protected] => https://mb.cision.com/Main/14691/3499134/1530142.pdf
[FileName:protected] => wkr0006.pdf
[Title:protected] => Invitation to Episurf Medical’s Q4 2021 presentation
[Description:protected] => Invitation to Episurf Medical’s Q4 2021 presentation
[CreateDate:protected] => 2022-02-04T11:00:09.28Z
[Keywords:protected] => Array
(
)
[Extension:protected] => pdf
)
)
[Quotes:protected] => Array
(
)
[ExternalLinks:protected] => Array
(
)
[EmbeddedItems:protected] => Array
(
)
[Id:protected] => 4175569
[EncryptedId:protected] => 6F11722ABF2B49E6
[IsRegulatory:protected] =>
[PublishDate:protected] => 2022-02-04T11:00:00Z
[LastChangeDate:protected] => 2022-02-04T11:00:09.263Z
[Title:protected] => Invitation to Episurf Medical’s Q4 2021 presentation
[Intro:protected] =>
[IptcCode:protected] => 04016003
[InformationType:protected] => PRM
[LanguageCode:protected] => en
[CountryCode:protected] => se
[CanonicalUrl:protected] =>
[CisionWireUrl:protected] => https://news.cision.com/episurf/r/invitation-to-episurf-medical-s-q4-2021-presentation,c3499134
[LanguageVersions:protected] => Array
(
[0] => CisionBlockPro\Cision\LanguageVersion Object
(
[Code:protected] => sv
[ReleaseId:protected] => 4175567
)
)
[Images:protected] => Array
(
)
[Tickers:protected] => Array
(
[0] => stdClass Object
(
[Symbol] => EPIS B
[ISIN] => SE0003491562
[PrimaryListing] => 1
[IsShare] => 1
[MarketPlaceSymbol] => STO
[MarketPlaceName] => Stockholmsbörsen
[MarketPlaceBloombergCode] => SS
[MarketPlaceMarketWireCode] => OMX
[MarketPlaceIsRegulated] => 1
[MarketPlaceCountryCode] => SE
)
)
)